These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 20675684)

  • 1. Characterization of human single-chain antibodies against highly pathogenic avian influenza H5N1 viruses: mimotope and neutralizing activity.
    Yang J; Yoshida R; Kariya Y; Zhang X; Hashiguchi S; Nakashima T; Suda Y; Takada A; Ito Y; Sugimura K
    J Biochem; 2010 Oct; 148(4):507-15. PubMed ID: 20675684
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vaccines with MF59 adjuvant expand the antibody repertoire to target protective sites of pandemic avian H5N1 influenza virus.
    Khurana S; Chearwae W; Castellino F; Manischewitz J; King LR; Honorkiewicz A; Rock MT; Edwards KM; Del Giudice G; Rappuoli R; Golding H
    Sci Transl Med; 2010 Jan; 2(15):15ra5. PubMed ID: 20371470
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative efficacy of North American and antigenically matched reverse genetics derived H5N9 DIVA marker vaccines against highly pathogenic Asian H5N1 avian influenza viruses in chickens.
    Jadhao SJ; Lee CW; Sylte M; Suarez DL
    Vaccine; 2009 Oct; 27(44):6247-60. PubMed ID: 19686695
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epitope mapping of neutralizing monoclonal antibody in avian influenza A H5N1 virus hemagglutinin.
    Ohkura T; Kikuchi Y; Kono N; Itamura S; Komase K; Momose F; Morikawa Y
    Biochem Biophys Res Commun; 2012 Feb; 418(1):38-43. PubMed ID: 22226969
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Broad cross-protection against H5N1 avian influenza virus infection by means of monoclonal antibodies that map to conserved viral epitopes.
    Chen Y; Qin K; Wu WL; Li G; Zhang J; Du H; Ng MH; Shih JW; Peiris JS; Guan Y; Chen H; Xia N
    J Infect Dis; 2009 Jan; 199(1):49-58. PubMed ID: 19032063
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Highly conserved sequences for human neutralization epitope on hemagglutinin of influenza A viruses H3N2, H1N1 and H5N1: Implication for human monoclonal antibody recognition.
    Yamashita A; Kawashita N; Kubota-Koketsu R; Inoue Y; Watanabe Y; Ibrahim MS; Ideno S; Yunoki M; Okuno Y; Takagi T; Yasunaga T; Ikuta K
    Biochem Biophys Res Commun; 2010 Mar; 393(4):614-8. PubMed ID: 20152806
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hemagglutinin pseudotyped lentiviral particles: characterization of a new method for avian H5N1 influenza sero-diagnosis.
    Nefkens I; Garcia JM; Ling CS; Lagarde N; Nicholls J; Tang DJ; Peiris M; Buchy P; Altmeyer R
    J Clin Virol; 2007 May; 39(1):27-33. PubMed ID: 17409017
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human 4F5 single-chain Fv antibody recognizing a conserved HA1 epitope has broad neutralizing potency against H5N1 influenza A viruses of different clades.
    Zhang X; Qi X; Zhang Q; Zeng X; Shi Z; Jin Q; Zhan F; Xu Y; Liu Z; Feng Z; Jiao Y
    Antiviral Res; 2013 Aug; 99(2):91-9. PubMed ID: 23680121
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic analysis of avian influenza A viruses isolated from domestic waterfowl in live-bird markets of Hanoi, Vietnam, preceding fatal H5N1 human infections in 2004.
    Jadhao SJ; Nguyen DC; Uyeki TM; Shaw M; Maines T; Rowe T; Smith C; Huynh LP; Nghiem HK; Nguyen DH; Nguyen HK; Nguyen HH; Hoang LT; Nguyen T; Phuong LS; Klimov A; Tumpey TM; Cox NJ; Donis RO; Matsuoka Y; Katz JM
    Arch Virol; 2009; 154(8):1249-61. PubMed ID: 19578928
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Free energy simulations reveal a double mutant avian H5N1 virus hemagglutinin with altered receptor binding specificity.
    Das P; Li J; Royyuru AK; Zhou R
    J Comput Chem; 2009 Aug; 30(11):1654-63. PubMed ID: 19399777
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of an influenza A H5N2 reassortant as a candidate for live-attenuated and inactivated vaccines against highly pathogenic H5N1 viruses with pandemic potential.
    Desheva JA; Lu XH; Rekstin AR; Rudenko LG; Swayne DE; Cox NJ; Katz JM; Klimov AI
    Vaccine; 2006 Nov; 24(47-48):6859-66. PubMed ID: 17050041
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Level of protection of chickens against highly pathogenic H5 avian influenza virus with Newcastle disease virus based live attenuated vector vaccine depends on homology of H5 sequence between vaccine and challenge virus.
    Römer-Oberdörfer A; Veits J; Helferich D; Mettenleiter TC
    Vaccine; 2008 May; 26(19):2307-13. PubMed ID: 18395947
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunohistochemical detection of Influenza virus infection in formalin-fixed tissues with anti-H5 monoclonal antibody recognizing FFWTILKP.
    He F; Du Q; Ho Y; Kwang J
    J Virol Methods; 2009 Jan; 155(1):25-33. PubMed ID: 18930768
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Generation of an attenuated H5N1 avian influenza virus vaccine with all eight genes from avian viruses.
    Shi H; Liu XF; Zhang X; Chen S; Sun L; Lu J
    Vaccine; 2007 Oct; 25(42):7379-84. PubMed ID: 17870216
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protection of chickens against H5N1 highly pathogenic avian influenza virus infection by live vaccination with infectious laryngotracheitis virus recombinants expressing H5 hemagglutinin and N1 neuraminidase.
    Pavlova SP; Veits J; Keil GM; Mettenleiter TC; Fuchs W
    Vaccine; 2009 Jan; 27(5):773-85. PubMed ID: 19041677
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Generation, characterization and epitope mapping of two neutralizing and protective human recombinant antibodies against influenza A H5N1 viruses.
    Sun L; Lu X; Li C; Wang M; Liu Q; Li Z; Hu X; Li J; Liu F; Li Q; Belser JA; Hancock K; Shu Y; Katz JM; Liang M; Li D
    PLoS One; 2009; 4(5):e5476. PubMed ID: 19421326
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influenza vaccines and vaccination strategies in birds.
    van den Berg T; Lambrecht B; Marché S; Steensels M; Van Borm S; Bublot M
    Comp Immunol Microbiol Infect Dis; 2008 Mar; 31(2-3):121-65. PubMed ID: 17889937
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Generation of neutralizing recombinant human antibodies for targeting highly pathogenic avian influenza A (H5N1) virus].
    Sun LN; Liu QZ; Wang M; Li C; Li Z; Hu XF; Zhu LL; Li Q; Wang SW; Shu YL; Liang MF; Li DX
    Bing Du Xue Bao; 2008 May; 24(3):165-71. PubMed ID: 18683551
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protective efficacy of several vaccines against highly pathogenic H5N1 avian influenza virus under experimental conditions.
    Veits J; Römer-Oberdörfer A; Helferich D; Durban M; Suezer Y; Sutter G; Mettenleiter TC
    Vaccine; 2008 Mar; 26(13):1688-96. PubMed ID: 18291561
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serosurveillance study on transmission of H5N1 virus during a 2006 avian influenza epidemic.
    Ceyhan M; Yildirim I; Ferraris O; Bouscambert-Duchamp M; Frobert E; Uyar N; Tezer H; Oner AF; Buzgan T; Torunoglu MA; Ozkan B; Yilmaz R; Kurtoglu MG; Laleli Y; Badur S; Lina B
    Epidemiol Infect; 2010 Sep; 138(9):1274-80. PubMed ID: 20092669
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.